Controversy about the relative efficacy of dipeptidyl peptidase IV inhibitors
Author:
Open Access
- 7 July 2012
- journal article
- letter
- Published by Springer Nature in Diabetologia
- Vol. 55 (10) , 2848-2849
Abstract
No abstract availableKeywords
This publication has 8 references indexed in Scilit:
- Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)Diabetologia, 2012
- DPP-4 inhibitors in the management of type 2 diabetes: A critical review of head-to-head trialsDiabetes & Metabolism, 2012
- Dipeptidyl peptidase-4 inhibitors for treatment of type 2 diabetes mellitus in the clinical setting: systematic review and meta-analysisBMJ, 2012
- A review of gliptins in 2011Expert Opinion on Pharmacotherapy, 2011
- Effect of Noninsulin Antidiabetic Drugs Added to Metformin Therapy on Glycemic Control, Weight Gain, and Hypoglycemia in Type 2 DiabetesJAMA, 2010
- Is the ADA/EASD algorithm for the management of type 2 diabetes (January 2009) based on evidence or opinion? A critical analysisDiabetologia, 2010
- Relationship of baseline HbA1c and efficacy of current glucose‐lowering therapies: a meta‐analysis of randomized clinical trialsDiabetic Medicine, 2010
- Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapyDiabetologia, 2008